-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Deferasirox in Thalassemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Deferasirox in Thalassemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Deferasirox in Thalassemia Drug Details:Deferasirox (DST-0509, KDFX) is under development for the treatment of...
-
Product Insights
Hematology Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Hematology Pipeline Market Report Overview Hematology tests evaluate numerous conditions involving blood and its components and the tests that generate results immediately and can be done in a limited resource setting. The hematology pipeline market research report provides comprehensive information about the hematology pipeline reconstruction with a comparative analysis of the reconstruction at various stages of development and information about the clinical trials which are in progress. Key Segments ·      Immunohematology ·      Hematology Reagents ·      Hemostasis Calibrators and Controls ·      ...
-
Product Insights
Net Present Value Model: Zynteglo
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Zynteglo Drug Details Zynteglo (betibeglogene autotemcel)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – deferasirox
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry deferasirox Drug Details Deferasirox (DST-0509, KDFX) is under development for the treatment of iron...